BADLANDS RESOURCES INC (BLDS.CA) Fundamental Analysis & Valuation

TSX-V:BLDS • CA0566001099

Current stock price

0.185 CAD
0 (0%)
Last:

This BLDS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BLDS.CA Profitability Analysis

1.1 Basic Checks

  • BLDS had negative earnings in the past year.
  • In the past year BLDS has reported a negative cash flow from operations.
  • In the past 5 years BLDS always reported negative net income.
  • In the past 5 years BLDS always reported negative operating cash flow.
BLDS.CA Yearly Net Income VS EBIT VS OCF VS FCFBLDS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • BLDS has a worse Return On Assets (-1666.47%) than 88.69% of its industry peers.
Industry RankSector Rank
ROA -1666.47%
ROE N/A
ROIC N/A
ROA(3y)-510.54%
ROA(5y)-309.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLDS.CA Yearly ROA, ROE, ROICBLDS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • BLDS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLDS.CA Yearly Profit, Operating, Gross MarginsBLDS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BLDS.CA Health Analysis

2.1 Basic Checks

  • BLDS has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BLDS has more shares outstanding
  • BLDS has a worse debt/assets ratio than last year.
BLDS.CA Yearly Shares OutstandingBLDS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BLDS.CA Yearly Total Debt VS Total AssetsBLDS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • BLDS has an Altman-Z score of -116.15. This is a bad value and indicates that BLDS is not financially healthy and even has some risk of bankruptcy.
  • BLDS's Altman-Z score of -116.15 is on the low side compared to the rest of the industry. BLDS is outperformed by 82.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -116.15
ROIC/WACCN/A
WACCN/A
BLDS.CA Yearly LT Debt VS Equity VS FCFBLDS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • BLDS has a Current Ratio of 0.02. This is a bad value and indicates that BLDS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BLDS's Current ratio of 0.02 is on the low side compared to the rest of the industry. BLDS is outperformed by 86.86% of its industry peers.
  • BLDS has a Quick Ratio of 0.02. This is a bad value and indicates that BLDS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BLDS has a worse Quick ratio (0.02) than 86.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
BLDS.CA Yearly Current Assets VS Current LiabilitesBLDS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BLDS.CA Growth Analysis

3.1 Past

  • BLDS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1306.30%.
EPS 1Y (TTM)-1306.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. BLDS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BLDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLDS.CA Price Earnings VS Forward Price EarningsBLDS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLDS.CA Per share dataBLDS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLDS.CA Dividend Analysis

5.1 Amount

  • BLDS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLDS.CA Fundamentals: All Metrics, Ratios and Statistics

BADLANDS RESOURCES INC

TSX-V:BLDS (3/12/2026, 7:00:00 PM)

0.185

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-26
Earnings (Next)07-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.98%
Ins Owner ChangeN/A
Market Cap2.09M
Revenue(TTM)N/A
Net Income(TTM)-11.86M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1666.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-510.54%
ROA(5y)-309.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -116.15
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1306.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y74.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.59%
OCF growth 3YN/A
OCF growth 5YN/A

BADLANDS RESOURCES INC / BLDS.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BADLANDS RESOURCES INC?

ChartMill assigns a fundamental rating of 0 / 10 to BLDS.CA.


What is the valuation status for BLDS stock?

ChartMill assigns a valuation rating of 0 / 10 to BADLANDS RESOURCES INC (BLDS.CA). This can be considered as Overvalued.


What is the profitability of BLDS stock?

BADLANDS RESOURCES INC (BLDS.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for BLDS stock?

The financial health rating of BADLANDS RESOURCES INC (BLDS.CA) is 0 / 10.